Fredun Pharma Director Acquires 1.06L Shares via Warrants

Fredun Pharmaceuticals discloses insider trading form under SEBI PIT Regulations 2015 for director shareholding change.
Fredun Nariman Medhora acquired 1,06,668 equity shares via preferential allotment on conversion of warrants on 25 March 2026.
Post-acquisition, Medhora's holding rose from 1,79,672 shares (3.35%) to 2,86,340 shares (5.23%), valued at ₹13.33 crore.